Carmen Retana1, Elsa Sanchez2, Alejandro Perez-Lopez3, Armando Cruz4, Jesus Lagunas4, Carmen Cruz5, Socorro Vital6, Jose L Reyes2. 1. Pharmacology Dept., Centre for Research and Advanced Studies National Polytechnic Institute, Mexico. 2. Physiology, Biophysics and Neurosciences Dept., Centre for Research and Advanced Studies National Polytechnic Institute, Mexico. 3. Dept. of Nephrology, Hospital Central Norte de PEMEX, Mexico. 4. Unidad Medica Alta Especialidad, Hospital General la Raza, Instituto Mexicano del Seguro Social (IMSS), Mexico. 5. Dept. of Nephrology, Hospital Regional No. 1 del IMSS, Mexico. 6. Dept. of Nephrology, Hospital Juarez de Mexico, Mexico.
Abstract
BACKGROUND: Dialysis patients are classified according to their peritoneal permeability as low transporter (LT, low solute permeability) or high transporter (HT, high solute permeability). Tight junction (TJ) proteins are critical to maintain ions, molecules and water paracellular transport through peritoneum. Exposure to peritoneal dialysis solutions causes damage to TJ in human peritoneal mesothelial cells (HPMCs). We analyzed the quantity, distribution and function of TJ proteins: claudin-1, -2 and -8, ZO-1 and occludin, in HPMC cultures from LT and HT patients. Since all-trans retinoic acid (ATRA) might modify the expression of TJ proteins, we studied its effect on HPMCs. METHODS: Control HPMCs were isolated from human omentum, while HT or LT cells were obtained from dialysis effluents. Cells were cultured in presence of ATRA 0, 50 or 100 nM. Transepithelial electrical resistance (TER) measurement, immunostaining and Western blot analyses were performed. RESULTS: HT exhibited lower TER than control and LT monolayers. Immunofluorescence for TJ was weak and discontinuous along the cell contour, in LT and HT. Furthermore, claudin-1, occludin and ZO-1 expressions were decreased. In all groups, claudin-2 was localized at nuclei. We observed that ATRA improved TJ distribution and increased TJ expression in HT. This retinoid did not modify claudin-2 and -8 expressions. All-trans retinoic acid decreased TER in HT, but had no effect in LT. CONCLUSIONS: Tight junctions were altered in HPMCs from dialyzed patients. The HT monolayer has lower TER than LT, which might be associated with the peritoneal permeability in these patients. ATRA might be a therapeutic alternative to maintain mesothelial integrity, since it improved TJ localization and expression.
BACKGROUND: Dialysis patients are classified according to their peritoneal permeability as low transporter (LT, low solute permeability) or high transporter (HT, high solute permeability). Tight junction (TJ) proteins are critical to maintain ions, molecules and water paracellular transport through peritoneum. Exposure to peritoneal dialysis solutions causes damage to TJ in human peritoneal mesothelial cells (HPMCs). We analyzed the quantity, distribution and function of TJ proteins: claudin-1, -2 and -8, ZO-1 and occludin, in HPMC cultures from LT and HT patients. Since all-trans retinoic acid (ATRA) might modify the expression of TJ proteins, we studied its effect on HPMCs. METHODS: Control HPMCs were isolated from human omentum, while HT or LT cells were obtained from dialysis effluents. Cells were cultured in presence of ATRA 0, 50 or 100 nM. Transepithelial electrical resistance (TER) measurement, immunostaining and Western blot analyses were performed. RESULTS: HT exhibited lower TER than control and LT monolayers. Immunofluorescence for TJ was weak and discontinuous along the cell contour, in LT and HT. Furthermore, claudin-1, occludin and ZO-1 expressions were decreased. In all groups, claudin-2 was localized at nuclei. We observed that ATRA improved TJ distribution and increased TJ expression in HT. This retinoid did not modify claudin-2 and -8 expressions. All-trans retinoic acid decreased TER in HT, but had no effect in LT. CONCLUSIONS: Tight junctions were altered in HPMCs from dialyzed patients. The HT monolayer has lower TER than LT, which might be associated with the peritoneal permeability in these patients. ATRA might be a therapeutic alternative to maintain mesothelial integrity, since it improved TJ localization and expression.
Authors: Lorenza Gonzalez-Mariscal; Maria Del Carmen Namorado; Dolores Martin; Gerardo Sierra; Jose L Reyes Journal: Nephrol Dial Transplant Date: 2006-06-09 Impact factor: 5.992
Authors: L Gonzalez-Mariscal; M C Namorado; D Martin; J Luna; L Alarcon; S Islas; L Valencia; P Muriel; L Ponce; J L Reyes Journal: Kidney Int Date: 2000-06 Impact factor: 10.612
Authors: Asher A Mendelson; Qiunong Guan; Irina Chafeeva; Gerald A da Roza; Jayachandran N Kizhakkedathu; Caigan Du Journal: Perit Dial Int Date: 2013 Jan-Feb Impact factor: 1.756
Authors: Martyna Pakuła; Anna Witucka; Paweł Uruski; Artur Radziemski; Rafał Moszyński; Dariusz Szpurek; Konstantin Maksin; Aldona Woźniak; Stefan Sajdak; Andrzej Tykarski; Justyna Mikuła-Pietrasik; Krzysztof Książek Journal: Sci Rep Date: 2019-05-20 Impact factor: 4.379
Authors: Maria Bartosova; Rebecca Herzog; David Ridinger; Eszter Levai; Hanna Jenei; Conghui Zhang; Guadalupe T González Mateo; Iva Marinovic; Thilo Hackert; Felix Bestvater; Michael Hausmann; Manuel López Cabrera; Klaus Kratochwill; Sotirios G Zarogiannis; Claus Peter Schmitt Journal: Biomolecules Date: 2020-08-13
Authors: Andres Isaza-Restrepo; Juan S Martin-Saavedra; Juan L Velez-Leal; Felipe Vargas-Barato; Rafael Riveros-Dueñas Journal: Front Physiol Date: 2018-06-15 Impact factor: 4.566
Authors: Katherine M DiGuilio; Elizabeth Rybakovsky; Reza Abdavies; Romy Chamoun; Colleen A Flounders; Ariel Shepley-McTaggart; Ronald N Harty; James M Mullin Journal: Int J Mol Sci Date: 2022-03-10 Impact factor: 5.923